ACCELERATED CLINICAL TRIAL DESIGN TO ASSESS THE SAFETY, TOLERABILITY AND ANTI-VIRAL ACTIVITY OF PHX1766, A NOVEL HCV NS3/4A PROTEASE INHIBITOR, IN HEALTHY VOLUNTEERS AND CHRONIC HEPATITIS C PATIENTS
HEPATOLOGY(2009)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined